Medical News

RSS
YM BioSciences-Cytopia merger complete

YM BioSciences-Cytopia merger complete

Cordis, Boston Scientific agree to resolve two Delaware litigations related to coronary stent patents

Cordis, Boston Scientific agree to resolve two Delaware litigations related to coronary stent patents

Congressional leader stresses the importance of annual dilated eye exam for diabetes patients

Congressional leader stresses the importance of annual dilated eye exam for diabetes patients

Survey: Medicaid beats private insurance when it comes to prevention

Survey: Medicaid beats private insurance when it comes to prevention

University of Pittsburgh awarded $3.5M NIH grant for WaferGen Biosystems's SmartChip Real-Time PCR System

University of Pittsburgh awarded $3.5M NIH grant for WaferGen Biosystems's SmartChip Real-Time PCR System

BioBehavioral Diagnostics completes $10M Series B financing round

BioBehavioral Diagnostics completes $10M Series B financing round

Congress faces one-month deadline on doctor payment fix

Congress faces one-month deadline on doctor payment fix

Cephalon to acquire Swiss-based pharmaceutical company

Cephalon to acquire Swiss-based pharmaceutical company

Democrats work to restart health bill

Democrats work to restart health bill

Survey finds Americans hesitant to seek mental health for confidentiality reasons

Survey finds Americans hesitant to seek mental health for confidentiality reasons

FDA approves Allergan's JUVÉDERM XC dermal filler

FDA approves Allergan's JUVÉDERM XC dermal filler

U-M study finds increased body fat in boys is associated with later onset of puberty

U-M study finds increased body fat in boys is associated with later onset of puberty

Children of Spanish-speaking Hispanic mothers spend less time in front of TV

Children of Spanish-speaking Hispanic mothers spend less time in front of TV

Danaher acquires AB SCIEX and Molecular Devices

Danaher acquires AB SCIEX and Molecular Devices

Abbott signs licensing agreement with Pierre Fabre SA to develop and commercialize cancer antibody h224G11

Abbott signs licensing agreement with Pierre Fabre SA to develop and commercialize cancer antibody h224G11

Patients with rare autoimmune disease produce antibodies that disarm immune proteins

Patients with rare autoimmune disease produce antibodies that disarm immune proteins

First Edition: February 1, 2010

First Edition: February 1, 2010

Managing Myeloma reviews past accomplishments; discusses future goals in evolving therapeutic landscape

Managing Myeloma reviews past accomplishments; discusses future goals in evolving therapeutic landscape

Denim blue jeans ribbon campaign: an initiative to raise awareness about children with rare diseases

Denim blue jeans ribbon campaign: an initiative to raise awareness about children with rare diseases

GeckoSystems' in home personal robot trials continue to proceed with new insights

GeckoSystems' in home personal robot trials continue to proceed with new insights

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.